Settlements and Verdicts

GSK, Novartis to Pay $114.5 Million to Alabama in Medicaid Fraud

Alabama state court jury, after two days deliberation, has ordered GlaxoSmithKline and Novartis to pay a multimillion dollar settlement to the State for medicaid fraud.

The State originally accused the companies of overcharging Medicaid patients for prescription drugs from the early 1990s to the mid-2000s. In the court order Novartis will pay $33.7 million and GSK will pay $80.8 million in damages.

JUL-02-08: AL jury: GSK, Novartis will pay [FIERCE PHARMA: MEDICAID FRAUD]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.